Lilly To Increase Manufacturing Investment To $9 Billion At Newest Indiana Site to Boost Production For Tirzepatide And Pipeline Medicines
Eli Lilly and Company announced today that it has more than doubled its investment in its Lebanon manufacturing site with a new $5.3 billion commitment, increasing the company’s total investment in this site from $3.7 billion to $9 billion.
Read More